Skip links



New NIH-funded center could soon reduce the need for pharmaceutical trials on animals

The University of Rochester will house a new national center focused on using tissue-on-chip technology to develop drugs more rapidly and reduce the need for animal trials. The National Institutes of Health awarded a $7.5 million grant to establish the Translational Center for Barrier Microphysiological Systems (TraCe-bMPS) at Rochester

Using chatbots to advance Spanish-speaking patient outreach

In her latest study, Kim Kaphingst, ScD, director of cancer communication research at Huntsman Cancer Institute and professor of communications at the University of Utah, is using chatbots to reach Spanish-speaking patients and teach them about genetic testing.  Credit: Huntsman Cancer Institute In her latest

The hidden identity of leukemia

Researchers from Tokyo Medical and Dental University (TMDU) use various technologies to better characterize a rare form of leukemia on the molecular level Credit: Department of Pediatrics and Developmental Biology, TMDU Researchers from Tokyo Medical and Dental University (TMDU) use various technologies to better characterize

Leukaemia: Artificial intelligence provides support in diagnostics

Decisions on treatment for patients with acute myeloid leukemia (AML) – a highly aggressive form of leukemia – are based, among other things, on a series of certain genetic features of the disease; but at the time when a diagnosis is made, this information is not available.

Epigenetic therapy shows promise for endocrine-resistant breast cancer

Endocrine resistance – a major cause of breast cancer deaths – can be underpinned by an epigenetic change called DNA methylation, researchers at the Garvan Institute of Medical Research have discovered. The team successfully reversed this methylation to reduce cancer growth in patient-derived animal models.